Quantinuum Sets Pricing for Its Upsized Initial Public Offering
In a significant move for the company, Quantinuum Inc. has announced today the pricing of its upsized initial public offering (IPO), consisting of 28,000,000 shares of its Class A common stock. The shares are priced at $60.00 each, marking a substantial step as Quantinuum continues to strengthen its position in the quantum computing sector.
Quantinuum has also granted underwriters a 30-day option to purchase an additional 4,200,000 shares to accommodate for any overallocations, thus ensuring greater liquidity in the market post-offering. The trading of these shares is set to commence on the Nasdaq Global Market under the ticker symbol "QNT" starting June 4, 2026. The closing of the offering is anticipated on June 5, 2026, contingent on standard closing conditions.
Prominent financial institutions including J.P. Morgan and Morgan Stanley are serving as joint book-running managers for this offering, with Jefferies and Evercore ISI also playing key roles. Other participants include BofA Securities, UBS Investment Bank, Cantor, Mizuho, Needham & Company, Société Générale, and TD Cowen, alongside Craig-Hallum and Rosenblatt acting as co-managers.
The Securities and Exchange Commission (SEC) has declared effective a registration statement regarding this offering as of June 3, 2026. Investors can only acquire shares through a prospectus. Copies of the prospectus, once available, may be obtained from the following:
- - J.P. Morgan Securities LLC at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or via email at [email protected] and [email protected].
- - Morgan Stanley & Co. LLC, 180 Varick St, 2nd Floor, New York, NY 10014, Attention: Prospectus Department, or via email at [email protected].
- - Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Ave, New York, NY 10022, by phone at (877) 821-7388 or via email at [email protected].
- - Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd St, 35th Floor, New York, NY 10055, by phone 888-474-0200 or via email at [email protected].
This announcement does not constitute an offer to sell or the solicitation of an offer to purchase these securities. Furthermore, there will be no sale of these shares in states or jurisdictions where such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such states or jurisdictions.
About Quantinuum
Quantinuum is recognized as a leading quantum computing company that offers a comprehensive platform aimed at facilitating the deployment of quantum computing within real-world environments. The company has successfully commercially launched several generations of quantum systems based on the well-established QCCD architecture, paired with innovative designs and capabilities that achieve the industry's highest precision levels as demonstrated by the average fidelity of its two-qubit gates by December 31, 2025. Active engagements with market leaders across sectors such as pharmaceuticals, materials science, financial services, and both governmental and industrial markets further highlight Quantinuum's pivotal role in the advancement of quantum technology.
Headquartered in Broomfield, Colorado, Quantinuum also maintains additional facilities in the United States, UK, Germany, Japan, Qatar, and Singapore, thus positioning itself as a global player in the quantum space.